Live from the NIH registry
Studies recruiting near Lancaster right now
Top 25 of 105 recruiting studies, sorted by proximity — each links to its official registry page
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
Phase 2
Interventional 29 participants sought
City of Hope at Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: City of Hope Medical Center
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
City Of Hope - Antelope Valley /ID# 263138 — Lancaster, California (2.2 mi)
· Sponsor: AbbVie
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1035 — Santa Clarita, California (29.5 mi)
· Sponsor: Immunovant Sciences GmbH
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 19 — Palmdale, California (8.6 mi)
· Sponsor: BioStem Technologies
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Amicis Research Corporate — Santa Clarita, California (29.5 mi)
· Sponsor: Boehringer Ingelheim
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Om Research, LLC 1 — Lancaster, California (2.2 mi)
· Sponsor: Janssen Research & Development, LLC
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Focal Seizure, Epilepsy
Phase 3
Interventional 333 participants sought
Amicis Research Center — Palmdale, California (8.6 mi)
· Sponsor: Rapport Therapeutics Inc.
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Lancaster, California (2.2 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
Amicis Research Center - Valencia — Santa Clarita, California (29.5 mi)
· Sponsor: Boehringer Ingelheim
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Lancaster, California (2.2 mi)
· Sponsor: GlaxoSmithKline
Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population
CRC Screening, Microbiome
N/A
Interventional 1,436 participants sought
Gastro Care Institute — Lancaster, California (2.2 mi)
· Sponsor: Jubaan Ltd.
Trial to Test the Efficacy of Using Magnetic Fields to Stimulate the Back to Treat Chronic Lower Back Pain.
Lower Back Pain Chronic
N/A
Interventional 88 participants sought
412 Medical Group — Edwards Air Force Base, California (20.6 mi)
· Sponsor: Joe X. Zhang
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400006 — Lancaster, California (2.2 mi)
· Sponsor: Sanofi
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Antelope Valley Medical Center — Lancaster, California (2.2 mi)
· Sponsor: Pfizer
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 425 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Hoffmann-La Roche
Study of DONQ52 in Active Celiac Disease
Celiac Disease
Phase 2
Interventional 92 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Chugai Pharmaceutical
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: NRG Oncology
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
Gastro Care Institute — Lancaster, California (2.2 mi)
· Sponsor: Genentech, Inc.
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Juvenile Psoriatic Arthritis
Phase 3
Interventional 60 participants sought
Local Institution - 0038 — Lancaster, California (2.2 mi)
· Sponsor: Bristol-Myers Squibb
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Ulcerative Colitis
Phase 2
Interventional 252 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Eli Lilly and Company
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Renal Insufficiency, Chronic
Phase 3
Interventional 2,800 participants sought
Research Site — Lancaster, California (2.2 mi)
· Sponsor: AstraZeneca
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Eli Lilly and Company
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: SWOG Cancer Research Network
Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference
Colonic Polyps
N/A
Interventional 330 participants sought
Gastro Care Institute — Lancaster, California (2.2 mi)
· Sponsor: Capso Vision, Inc.